AllianceBernstein’s Fulcrum Therapeutics FULC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $513K | Buy |
74,590
+9,000
| +14% | +$61.9K | ﹤0.01% | 2629 |
|
|
2025
Q1 | $189K | Hold |
65,590
| – | – | ﹤0.01% | 2932 |
|
|
2024
Q4 | $308K | Hold |
65,590
| – | – | ﹤0.01% | 2859 |
|
|
2024
Q3 | $234K | Sell |
65,590
-157,392
| -71% | -$562K | ﹤0.01% | 2991 |
|
|
2024
Q2 | $1.38M | Buy |
222,982
+36,017
| +19% | +$223K | ﹤0.01% | 2142 |
|
|
2024
Q1 | $1.76M | Sell |
186,965
-52,493
| -22% | -$496K | ﹤0.01% | 1989 |
|
|
2023
Q4 | $1.62M | Buy |
239,458
+5,920
| +3% | +$40K | ﹤0.01% | 2049 |
|
|
2023
Q3 | $1.04M | Buy |
+233,538
| New | +$1.04M | ﹤0.01% | 2219 |
|
|
2023
Q2 | – | Sell |
-55,900
| Closed | -$159K | – | 3196 |
|
|
2023
Q1 | $159K | Buy |
55,900
+13,100
| +31% | +$37.3K | ﹤0.01% | 2961 |
|
|
2022
Q4 | $312K | Buy |
42,800
+5,200
| +14% | +$37.9K | ﹤0.01% | 2850 |
|
|
2022
Q3 | $304K | Buy |
37,600
+4,100
| +12% | +$33.1K | ﹤0.01% | 2856 |
|
|
2022
Q2 | $164K | Buy |
33,500
+11,900
| +55% | +$58.3K | ﹤0.01% | 3059 |
|
|
2022
Q1 | $511K | Hold |
21,600
| – | – | ﹤0.01% | 2664 |
|
|
2021
Q4 | $382K | Buy |
21,600
+5,000
| +30% | +$88.4K | ﹤0.01% | 2842 |
|
|
2021
Q3 | $468K | Hold |
16,600
| – | – | ﹤0.01% | 2769 |
|
|
2021
Q2 | $174K | Buy |
16,600
+900
| +6% | +$9.43K | ﹤0.01% | 3172 |
|
|
2021
Q1 | $185K | Hold |
15,700
| – | – | ﹤0.01% | 3063 |
|
|
2020
Q4 | $184K | Hold |
15,700
| – | – | ﹤0.01% | 3002 |
|
|
2020
Q3 | $125K | Buy |
15,700
+700
| +5% | +$5.57K | ﹤0.01% | 3035 |
|
|
2020
Q2 | $274K | Buy |
+15,000
| New | +$274K | ﹤0.01% | 2908 |
|
|
2019
Q4 | – | Sell |
-509,369
| Closed | -$3.38M | – | 3118 |
|
|
2019
Q3 | $3.38M | Buy |
+509,369
| New | +$3.38M | ﹤0.01% | 1617 |
|